Integrated Clinical-to-Commercial Biopharma Solutions
Formed in 2018 through the merger of INC Research and inVentiv Health, Syneos Health combines clinical development with commercialization services for biopharma clients. Taken private in September 2023 in a ~$7.1 billion transaction led by Elliott Investment Management, Patient Square Capital and Veritas Capital. Maintains a registered Irish entity and Dublin-based clinical project management staff at Riverside One.